CHTF8

gene
On this page

Also known as FLJ20400CTF8

Summary

CHTF8 (chromosome transmission fidelity factor 8, HGNC:24353) is a protein-coding gene on chromosome 16q22.1, encoding Chromosome transmission fidelity protein 8 homolog (P0CG13). Chromosome cohesion factor involved in sister chromatid cohesion and fidelity of chromosome transmission. It is a selective cancer dependency (DepMap: 57.0% of cell lines).

This gene encodes a short protein that forms part of the Ctf18 replication factor C (RFC) complex that occurs in both yeast and mammals. The heteroheptameric RFC complex plays a role in sister chromatid cohesion and may load the replication clamp PCNA (proliferating cell nuclear antigen) onto DNA during DNA replication and repair. This gene is ubiquitously expressed and has been shown to have reduced expression in renal and prostate tumors. Alternatively spliced transcript variants have been described. This gene has a pseudogene on chromosome X.

Source: NCBI Gene 54921 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 23 total
  • Cancer dependency (DepMap): dependent in 57.0% of screened cell lines
  • MANE Select transcript: NM_001039690

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24353
Approved symbolCHTF8
Namechromosome transmission fidelity factor 8
Location16q22.1
Locus typegene with protein product
StatusApproved
AliasesFLJ20400, CTF8
Ensembl geneENSG00000168802
Ensembl biotypeprotein_coding
OMIM613202
Entrez54921

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 5 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000398235, ENST00000448552, ENST00000518041, ENST00000519534, ENST00000522091, ENST00000522497, ENST00000523421, ENST00000567763

RefSeq mRNA: 2 — MANE Select: NM_001039690 NM_001039690, NM_001040146

CCDS: CCDS42185

Canonical transcript exons

ENST00000448552 — 4 exons

ExonStartEnd
ENSE000020918636913248469132588
ENSE000035466956911801069120649
ENSE000036810576912105369121170
ENSE000038493226912143669121493

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 95.03.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 51.5794 / max 263.1907, expressed in 1820 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
15789151.57941820
1578901.99191160

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
granulocyteCL:000009495.03gold quality
adult mammalian kidneyUBERON:000008294.99gold quality
mucosa of transverse colonUBERON:000499194.92gold quality
apex of heartUBERON:000209894.61gold quality
leukocyteCL:000073894.39gold quality
monocyteCL:000057694.34gold quality
islet of LangerhansUBERON:000000694.16gold quality
right lobe of liverUBERON:000111493.96gold quality
smooth muscle tissueUBERON:000113593.72gold quality
right lobe of thyroid glandUBERON:000111993.05gold quality
lower esophagus mucosaUBERON:003583493.03gold quality
fallopian tubeUBERON:000388992.97gold quality
right uterine tubeUBERON:000130292.91gold quality
pancreasUBERON:000126492.87gold quality
spleenUBERON:000210692.65gold quality
body of stomachUBERON:000116192.56gold quality
left adrenal glandUBERON:000123492.51gold quality
metanephros cortexUBERON:001053392.51gold quality
body of pancreasUBERON:000115092.48gold quality
left adrenal gland cortexUBERON:003582592.42gold quality
right testisUBERON:000453492.41gold quality
stromal cell of endometriumCL:000225592.40gold quality
prostate glandUBERON:000236792.39gold quality
right adrenal glandUBERON:000123392.28gold quality
fundus of stomachUBERON:000116092.23gold quality
lymph nodeUBERON:000002992.18gold quality
liverUBERON:000210792.14gold quality
right adrenal gland cortexUBERON:003582792.10gold quality
left testisUBERON:000453392.05gold quality
left lobe of thyroid glandUBERON:000112092.04gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.69

Regulation

Is transcription factor: no

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 57.0% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 3)

  • hCTF18, hCTF8, and hDCC1 interact with each other as well as with the p38 subunit of RFC (PMID:12766176)
  • The alternative Ctf18-Dcc1-Ctf8-replication factor C complex required for sister chromatid cohesion loads proliferating cell nuclear antigen onto DNA. (PMID:12930902)
  • Stable interaction between the human proliferating cell nuclear antigen loader complex Ctf18-replication factor C (RFC) and DNA polymerase {epsilon} is mediated by the cohesion-specific subunits, Ctf18, Dcc1, and Ctf8. (PMID:20826785)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriochtf8ENSDARG00000069045
mus_musculusChtf8ENSMUSG00000046691
drosophila_melanogasterCG34001FBGN0054001
caenorhabditis_elegansctf-8WBGENE00011915

Protein

Protein identifiers

Chromosome transmission fidelity protein 8 homologP0CG13 (reviewed: P0CG13)

All UniProt accessions (5): P0CG13, E5RGY5, E5RHL4, H3BQB7, J3KSJ7

UniProt curated annotations — full annotation on UniProt →

Function. Chromosome cohesion factor involved in sister chromatid cohesion and fidelity of chromosome transmission. Component of one of the cell nuclear antigen loader complexes, CTF18-replication factor C (CTF18-RFC), which consists of CTF18, CTF8, DSCC1, RFC2, RFC3, RFC4 and RFC5. The CTF18-RFC complex binds to single-stranded and primed DNAs and has weak ATPase activity that is stimulated the presence of primed DNA, replication protein A (RPA) and proliferating cell nuclear antigen (PCNA). The CTF18-RFC complex catalyzes the ATP-dependent loading of PCNA onto primed and gapped DNA. It also interacts with and stimulates POLH, which is suggestive of a protein network that coordinates DNA repair, recombination and chromosome cohesion reactions with replication fork progression.

Subunit / interactions. Component of the CTF18-RFC complex, which consists of CTF18, CTF8, DSCC1, RFC2, RFC3, RFC4 and RFC5. The CTF18-RFC complex does not interact with the Rad9/Rad1/Hus1 complex. The CTF18-RFC complex interacts with POLH. CTF18/CTF8/DSCC1 associate with PCNA. CTF8 exists as a dimer with DSCC1.

Subcellular location. Nucleus.

Similarity. Belongs to the CTF8 family.

RefSeq proteins (2): NP_001034779, NP_001035236 (=MANE)

Domains & families (InterPro)

IDNameType
IPR018607Ctf8Family

Pfam: PF09696

UniProt features (1 total): chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-P0CG13-F186.990.61

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-174411Polymerase switching on the C-strand of the telomere

MSigDB gene sets: 123 (showing top): GOBP_CHROMOSOME_ORGANIZATION, GOBP_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS, chr16q22, GOBP_REGULATION_OF_TRANSFERASE_ACTIVITY, GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY, GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION, GOBP_SISTER_CHROMATID_COHESION, GOBP_DNA_BIOSYNTHETIC_PROCESS, REACTOME_EXTENSION_OF_TELOMERES, GOBP_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS, RASHI_RESPONSE_TO_IONIZING_RADIATION_5, GOBP_DNA_REPLICATION, GOBP_MITOTIC_SISTER_CHROMATID_COHESION, GOBP_CELL_CYCLE_PROCESS, GOBP_DNA_METABOLIC_PROCESS

GO Biological Process (3): DNA replication (GO:0006260), mitotic sister chromatid cohesion (GO:0007064), positive regulation of DNA-directed DNA polymerase activity (GO:1900264)

GO Molecular Function (4): DNA binding (GO:0003677), DNA clamp loader activity (GO:0003689), protein binding (GO:0005515), single-stranded DNA helicase activity (GO:0017116)

GO Cellular Component (3): nucleoplasm (GO:0005654), Ctf18 RFC-like complex (GO:0031390), nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Telomere C-strand (Lagging Strand) Synthesis1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
DNA metabolic process1
DNA biosynthetic process1
sister chromatid cohesion1
DNA-directed DNA polymerase activity1
positive regulation of catalytic activity1
regulation of transferase activity1
positive regulation of DNA biosynthetic process1
nucleic acid binding1
DNA binding1
ATP-dependent activity, acting on DNA1
binding1
DNA helicase activity1
nuclear lumen1
cellular anatomical structure1
chromosome1
nuclear protein-containing complex1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

708 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CHTF8CHTF18Q8WVB6999
CHTF8DSCC1Q9BVC3999
CHTF8RFC2P32846989
CHTF8RFC5P40937978
CHTF8RFC3P40938970
CHTF8SMC3Q9UQE7910
CHTF8RFC4P35249909
CHTF8ESCO1Q5FWF5878
CHTF8WAPLQ7Z5K2849
CHTF8WDHD1O75717838
CHTF8PDS5AQ29RF7832
CHTF8ESCO2Q56NI9822
CHTF8RAD21O60216732
CHTF8ATAD5Q96QE3723
CHTF8RAD17O75943672

IntAct

27 interactions, top by confidence:

ABTypeScore
PSMC3PSMD9psi-mi:“MI:0914”(association)0.940
RFC5RAD17psi-mi:“MI:0914”(association)0.730
RFC4RAD17psi-mi:“MI:0914”(association)0.730
CHTF8IL36Apsi-mi:“MI:0915”(physical association)0.670
DSCC1CHTF8psi-mi:“MI:0914”(association)0.530
FKBP9CASC3psi-mi:“MI:0914”(association)0.530
CHTF8AP4M1psi-mi:“MI:0915”(physical association)0.370
FKBP9COL2A1psi-mi:“MI:0914”(association)0.350
PPIEPLRG1psi-mi:“MI:0914”(association)0.350
RFC4RAD1psi-mi:“MI:0914”(association)0.350
IL36ARNF40psi-mi:“MI:0914”(association)0.350
RFC5RAD17psi-mi:“MI:0914”(association)0.350
KCTD12DUSP11psi-mi:“MI:0914”(association)0.350
CHTF18ALDOBpsi-mi:“MI:0914”(association)0.350
CPNE2SUPT5Hpsi-mi:“MI:0914”(association)0.350
KCTD12CYTH3psi-mi:“MI:0914”(association)0.350
RFC4A2ML1psi-mi:“MI:0914”(association)0.350
FHIP2AMED19psi-mi:“MI:2364”(proximity)0.270

BioGRID (48): CHTF8 (Affinity Capture-RNA), CHTF8 (Affinity Capture-RNA), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Two-hybrid), RFC3 (Affinity Capture-Western), CHTF8 (Proximity Label-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS), CHTF8 (Affinity Capture-MS)

ESM2 similar proteins: D3ZLY0, O08848, O35473, O95453, P0C6T1, P0CG11, P0CG13, P0CG15, P0CL18, P13984, P41214, P50747, P69341, Q01750, Q03123, Q05B58, Q13901, Q15650, Q2T9L9, Q2T9Y1, Q32PE4, Q3U2J5, Q5PPG7, Q5RA63, Q5RBU4, Q5RC51, Q5RK19, Q5U3V9, Q5ZHS3, Q6DC64, Q6GR37, Q6NYU2, Q6P4H8, Q7TSU0, Q80YV4, Q8BY71, Q8IVD9, Q8K2Q0, Q8R0A0, Q8R1T1

Diamond homologs: P0C6T1, P0CG11, P0CG13, P0CG15

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

23 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance18
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

568 predictions. Top by Δscore:

VariantEffectΔscore
16:69121166:TCGCA:Tacceptor_gain1.0000
16:69121167:CGCA:Cacceptor_gain1.0000
16:69121167:CGCAC:Cacceptor_gain1.0000
16:69121168:GCA:Gacceptor_gain1.0000
16:69121169:CA:Cacceptor_gain1.0000
16:69121169:CAC:Cacceptor_gain1.0000
16:69121170:ACTG:Aacceptor_loss1.0000
16:69121171:C:CAacceptor_loss1.0000
16:69121171:C:CCacceptor_gain1.0000
16:69121431:CTTA:Cdonor_loss1.0000
16:69121432:TTA:Tdonor_loss1.0000
16:69121433:TA:Tdonor_loss1.0000
16:69121434:ACC:Adonor_loss1.0000
16:69121435:C:CGdonor_loss1.0000
16:69121489:ACAAG:Aacceptor_gain1.0000
16:69121490:CAAG:Cacceptor_gain1.0000
16:69121490:CAAGC:Cacceptor_gain1.0000
16:69121491:AAG:Aacceptor_gain1.0000
16:69121492:AG:Aacceptor_gain1.0000
16:69121492:AGC:Aacceptor_loss1.0000
16:69121493:GC:Gacceptor_loss1.0000
16:69121494:C:CCacceptor_gain1.0000
16:69121494:C:Tacceptor_loss1.0000
16:69121495:T:Aacceptor_loss1.0000
16:69120649:CCTT:Cacceptor_gain0.9900
16:69121048:CTCA:Cdonor_loss0.9900
16:69121051:A:Tdonor_loss0.9900
16:69121052:C:CTdonor_loss0.9900
16:69121430:ACTT:Adonor_loss0.9900
16:69121434:A:ACdonor_gain0.9900

AlphaMissense

774 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
16:69120473:G:CF106L0.996
16:69120473:G:TF106L0.996
16:69120474:A:GF106S0.996
16:69120475:A:GF106L0.996
16:69120609:C:TG61E0.996
16:69120610:C:AG61W0.996
16:69120576:A:TV72D0.995
16:69120609:C:AG61V0.995
16:69120463:G:AP110S0.994
16:69120462:G:TP110H0.993
16:69120499:C:GA98P0.993
16:69120627:C:TG55E0.993
16:69120636:A:GL52P0.993
16:69120615:A:GL59P0.992
16:69120627:C:AG55V0.992
16:69121124:C:GG24R0.992
16:69121124:C:TG24R0.992
16:69120475:A:CF106V0.991
16:69120475:A:TF106I0.991
16:69120579:G:TA71E0.991
16:69121075:C:TG40E0.991
16:69120463:G:TP110T0.990
16:69120466:G:TR109S0.989
16:69120482:C:AK103N0.988
16:69120482:C:GK103N0.988
16:69121129:A:GL22P0.988
16:69121076:C:GG40R0.987
16:69121076:C:TG40R0.987
16:69121123:C:TG24E0.987
16:69120610:C:GG61R0.986

dbSNP variants (sampled 300 via entrez): RS1000311617 (16:69119977 G>A,C), RS1000537458 (16:69130925 T>C), RS1000769290 (16:69130528 C>A), RS1000915406 (16:69134408 G>C), RS1001210112 (16:69122032 C>A,T), RS1001282816 (16:69125686 A>C,G), RS1001868649 (16:69125805 G>A,C), RS1001898988 (16:69131595 C>A,G), RS1002171595 (16:69129710 TCTC>T), RS1002359386 (16:69126055 A>G), RS1002374308 (16:69131869 A>T), RS1002433966 (16:69117915 G>A), RS1002568418 (16:69134182 G>A), RS1002621283 (16:69120871 T>C), RS1002887875 (16:69118625 T>C)

Disease associations

OMIM: gene MIM:613202 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST005951_13Body mass index5.000000e-11
GCST010703_183Brain morphology (MOSTest)5.000000e-11

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004340body mass index
EFO:0004346neuroimaging measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

27 total (human), top 27 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects cotreatment, increases methylation, decreases expression2
Valproic Acidaffects expression, decreases expression2
GSK-J4decreases expression1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
sodium arseniteaffects cotreatment, decreases expression, increases abundance1
butyraldehydedecreases expression1
manganese chlorideaffects cotreatment, decreases expression, increases abundance1
ferrous chloridedecreases expression1
pentanaldecreases expression1
di-n-butylphosphoric acidaffects expression1
2,3,5-(triglutathion-S-yl)hydroquinoneincreases ADP-ribosylation1
14-deoxy-11,12-didehydroandrographolidedecreases expression1
abrineincreases expression1
7-(benzylamino)-1,3,4,8-tetrahydropyrrolo(4,3,2-de)quinolin-8(1H)-onedecreases expression1
Fulvestrantaffects cotreatment, increases methylation1
Leflunomidedecreases expression1
Air Pollutants, Occupationaldecreases expression1
Arsenicaffects cotreatment, decreases expression, increases abundance1
Atrazineincreases expression1
Doxorubicinincreases expression1
Ivermectindecreases expression1
Manganeseaffects cotreatment, decreases expression, increases abundance1
Nickeldecreases expression1
Quercetinincreases expression1
Tobacco Smoke Pollutionincreases expression1
Cyclosporinedecreases expression1
Lactic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.